Search Results - "Xie, Yingda"

Refine Results
  1. 1

    Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study by Dorman, Susan E, Schumacher, Samuel G, Alland, David, Nabeta, Pamela, Armstrong, Derek T, King, Bonnie, Hall, Sandra L, Chakravorty, Soumitesh, Cirillo, Daniela M, Tukvadze, Nestani, Bablishvili, Nino, Stevens, Wendy, Scott, Lesley, Rodrigues, Camilla, Kazi, Mubin I, Joloba, Moses, Nakiyingi, Lydia, Nicol, Mark P, Ghebrekristos, Yonas, Anyango, Irene, Murithi, Wilfred, Dietze, Reynaldo, Lyrio Peres, Renata, Skrahina, Alena, Auchynka, Vera, Chopra, Kamal Kishore, Hanif, Mahmud, Liu, Xin, Yuan, Xing, Boehme, Catharina C, Ellner, Jerrold J, Denkinger, Claudia M, Dorman, Susan E, Schumacher, Samuel G, Alland, David, Nabeta, Pamela, Armstrong, Derek T, King, Bonnie, Hall, Sandra L, Chakravorty, Soumitesh, Cirillo, Daniela M, Tukvadze, Nestani, Bablishvili, Nino, Stevens, Wendy, Scott, Lesley, Rodrigues, Camilla, Kazi, Mubin I, Joloba, Moses, Nakiyingi, Lydia, Nicol, Mark P, Ghebrekristos, Yonas, Anyango, Irene, Murithi, Wilfred, Dietze, Reynaldo, Peres, Renata Lyrio, Skrahina, Alena, Auchynka, Vera, Chopra, Kamal Kishore, Hanif, Mahmud, Liu, Xin, Yuan, Xing, Boehme, Catharina C, Ellner, Jerrold J, Denkinger, Claudia M, Manabe, Yukari C, Hom, David, Aspindzelashvili, Rusudan, David, Anura, Surve, Utkarsha, Kamulegeya, Louis Henry, Nabweyambo, Sheila, Surtie, Shireen, Hapeela, Nchimunya, Cain, Kevin P, Agaya, Janet, McCarthy, Kimberly D, Marques-Rodrigues, Patricia, Schmidt Castellani, Luiz Guilherme, Almeida, Pedro Sousa, de Aguiar, Paola Poloni Lobo, Solodovnikova, Varvara, Ruan, Xianglin, Liang, Lili, Zhang, Guolong, Zhu, Hong, Xie, Yingda

    Published in The Lancet infectious diseases (01-01-2018)
    “…The Xpert MTB/RIF assay is an automated molecular test that has improved the detection of tuberculosis and rifampicin resistance, but its sensitivity is…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review by Rao, Prakruti S., Modi, Nisha, Nguyen, Nam-Tien Tran, Vu, Dinh Hoa, Xie, Yingda L., Gandhi, Monica, Gerona, Roy, Metcalfe, John, Heysell, Scott K., Alffenaar, Jan-Willem C.

    Published in Clinical pharmacokinetics (01-03-2023)
    “…Background and Objective Quantifying exposure to drugs for personalized dose adjustment is of critical importance in patients with tuberculosis who may be at…”
    Get full text
    Journal Article
  4. 4
  5. 5

    New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS by Karaźniewicz-Łada, Marta, Kosicka-Noworzyń, Katarzyna, Rao, Prakruti, Modi, Nisha, Xie, Yingda L, Heysell, Scott K, Kagan, Leonid

    “…Successful tuberculosis (TB) therapy requires achieving sufficient exposure to multiple drugs. Limited stability of several first-line anti-TB drugs might…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing by Banada, Padmapriya, Elson, David, Daivaa, Naranjargal, Park, Claire, Desind, Samuel, Montalvan, Ibsen, Kwiatkowski, Robert, Chakravorty, Soumitesh, Alland, David, Xie, Yingda L

    Published in Journal of medical microbiology (01-09-2021)
    “…Non-invasive sample collection and viral sterilizing buffers have independently enabled workflows for more widespread COVID-19 testing by reverse-transcriptase…”
    Get full text
    Journal Article
  8. 8
  9. 9

    RT-PCR negative COVID-19 by Parmar, Heta, Montovano, Margaret, Banada, Padmapriya, Pentakota, Sri Ram, Shiau, Stephanie, Ma, Zhongjie, Saibire, Kaheerman, Chopoorian, Abby, O'Shaughnessy, Michael, Hirsch, Mitchell, Jain, Priyanshi, Demirdjian, Gaiane, Karagueuzian, Magali, Robin, Thomas, Salvati, Michael, Patel, Bhavana, Alland, David, Xie, Yingda L

    Published in BMC infectious diseases (13-02-2022)
    “…COVID-19 is a multi-system infection with emerging evidence-based antiviral and anti-inflammatory therapies to improve disease prognosis. However, a subset of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative by Xie, Yingda L, Cronin, Wendy A, Proschan, Michael, Oatis, Richard, Cohn, Silvia, Curry, Scott R, Golub, Jonathan E, Barry, Clifton E, Dorman, Susan E

    Published in Clinical infectious diseases (13-11-2018)
    “…We assessed the transmission risk of pulmonary tuberculosis patients whose sputum nucleic acid amplification tests (NAAT) were negative. We estimated that, at…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies by Xie, Yingda L., Rosen, Lindsey B., Sereti, Irini, Barber, Daniel L., Chen, Ray Y., Hsu, Denise C., Qasba, S. Sonia, Zerbe, Christa S., Holland, Steven M., Browne, Sarah K.

    Published in Clinical infectious diseases (15-03-2016)
    “…Interferon-gamma (IFNγ) neutralizing autoantibodies are associated with disseminated nontuberculous mycobacterial infections. We report a previously healthy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis by Abadie, Miriam E, Strich, Jeffrey R, Kim, Tiffany, Xie, Yingda L, Fennelly, Kevin P, Olivier, Kenneth N, Waldman, Meryl, Arora, Kriti, Holland, Steven M, Chen, Ray Y

    Published in The European respiratory journal (01-12-2017)
    “…We read with interest the papers by Tiberi et al. [1, 2] describing the effectiveness of meropenem/clavulanate in treating multidrug-resistant (MDR) and…”
    Get full text
    Journal Article
  20. 20